Clinical Trials
9 trialsNCT04357873 2025-02-19
PEVOsq
UNICANCER
Phase 2 Completed
NCT00455351 2023-05-08
PRAVO
Oslo University Hospital
Phase 1 Completed
NCT03509207 2020-08-04
Vorinostat (SAHA) in Uterine Sarcoma
Medical University of Graz
Phase 2 Terminated
NCT01249443 2020-07-29
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
AIDS Malignancy Consortium
Phase 1 Terminated
NCT00132067 2019-07-23
Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00910000 2018-09-10
Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer
Dana-Farber Cancer Institute
Phase 1/2 Terminated
NCT00976183 2017-04-10
Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma
Gynecologic Oncology Associates
Phase 1/2 Terminated
NCT00045006 2013-05-30
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00772798 2008-10-15
A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer
Herlev Hospital
Phase 2 Unknown